BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3190165)

  • 1. [Voided urinary cytodiagnosis. Cyto-histologic comparison].
    Zerat L; Fontanière B; Claude JM; Potet F; Verges J
    Ann Urol (Paris); 1988; 22(4):249-53. PubMed ID: 3190165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary cytology in symptomatic subjects: cyto-histological comparison in 124 cases].
    Pisa R; Piubello Q; Scarpa A; Novelli P; Baiocco R; Pea M; Marino F
    Pathologica; 1985; 77(1050):409-16. PubMed ID: 3834373
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytohistological study of urinary bladder neoplasms.
    Misra V; Gupta SC; Tandon SP; Gupta AK; Sircar S
    Indian J Pathol Microbiol; 2000 Jul; 43(3):303-9. PubMed ID: 11218677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The place of urinary cytology in the diagnosis of urothelial tumors].
    Mansat A; Pontonnier F; Plante P; Vincent MF; Lagorce C
    Bull Assoc Anat (Nancy); 1983 Mar; 67(196):141-50. PubMed ID: 6640127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
    Casella R; Huber P; Blöchlinger A; Stoffel F; Dalquen P; Gasser TC; Lehmann K
    J Urol; 2000 Dec; 164(6):1926-8. PubMed ID: 11061883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
    Garbar C; Mascaux C; Wespes E
    Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of urinary cytology in bladder tumors--analysis of factors related with positivity of urinary cytology].
    Tanaka K; Takashi M; Sahashi M; Shimoji T; Miyake K; Koshikawa T; Shiral T; Kawashima K; Nakajima N; Hamajima N
    Hinyokika Kiyo; 1990 Jan; 36(1):7-11. PubMed ID: 1689930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of urinary cytology in the diagnosis of neoplasms of the upper excretory tract. Cyto-histological correlations in 29 cases].
    Mincione GP; Muraro GB; Pecori M; Rossi I
    Pathologica; 1983; 75(1036):181-6. PubMed ID: 6634230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary cytology for carcinoma of the urinary bladder].
    Nagumo S; Matuda M; Kuroda M
    Rinsho Byori; 1992 Jul; 40(7):728-35. PubMed ID: 1507491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of transitional cell carcinoma of the urinary bladder. Comparison with endoscopical and pathological findings on 538 cases.
    Raica M; Minciu R; Miclea F; Botoca M; Drăgan P; Ioiart I
    Rom J Morphol Embryol; 1997; 43(3-4):155-61. PubMed ID: 9747115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bladder tumors: superiority of urinary cytology after bladder lavage].
    Boccon-Gibod L; Loridon B; Boccon-Gibod L; Deslignières S
    Ann Urol (Paris); 1985; 19(6):389-91. PubMed ID: 4096512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
    Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
    Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of cytology of voided urine.
    Koss LG; Deitch D; Ramanathan R; Sherman AB
    Acta Cytol; 1985; 29(5):810-6. PubMed ID: 3863429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.